구강용 박막 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global oral thin films market size is expected to reach USD 16.24 Billion in 2034 from USD 5.58 Billion in 2025, growing at a CAGR of 12.59 during 2026-2034.This market has experienced significant growth due to increasing demand for convenient and patient-friendly drug delivery systems. Oral thin films provide rapid dissolution, ease of administration, and improved medication adherence, making them particularly suitable for pediatric, geriatric, and dysphagic patients. The pharmaceutical industry's focus on innovative dosage forms has accelerated adoption across various therapeutic applications. Rising healthcare awareness and the growing prevalence of chronic diseases have further contributed to market expansion globally.

The major growth drivers include advancements in pharmaceutical formulation technologies, increasing demand for fast-acting medications, and growing preference for non-invasive drug delivery methods. Oral thin films offer advantages such as accurate dosing, portability, and enhanced bioavailability, making them attractive alternatives to conventional tablets and capsules. Pharmaceutical companies are investing heavily in research and development activities to expand product portfolios. Additionally, supportive regulatory pathways for novel drug delivery systems continue to encourage market growth.

Future prospects remain highly favorable as personalized medicine and patient-centric healthcare gain greater importance. Technological innovations are expected to improve film stability, drug-loading capacity, and therapeutic effectiveness. Expanding applications in nutraceuticals and over-the-counter products will create additional growth opportunities. Emerging healthcare markets and increasing consumer acceptance of advanced drug delivery technologies are anticipated to support sustained market expansion in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Sublingual Film
• Fast Dissolving Dental/Buccal Film

By Disease Indication

• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Other Disease Indication

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels

COMPANIES PROFILED

• ZIM Laboratories Limited, NAL Pharma, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., Sunovion Pharmaceuticals Inc., Seoul Pharma Co. Ltd., Aquestive Therapeutics Inc., Shilpa Therapeutics Pvt. Ltd., Mylan Inc., LIVKON Pharmaceuticals Pvt. Ltd

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORAL THIN FILMS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Sublingual Film Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Fast Dissolving Dental/Buccal Film Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORAL THIN FILMS MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Indication
• 5.2. Schizophrenia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Migraine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Opioid Dependence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nausea & Vomiting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Disease Indication Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORAL THIN FILMS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORAL THIN FILMS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Disease Indication
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Disease Indication
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Disease Indication
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Disease Indication
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Disease Indication
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ORAL THIN FILMS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 ZIM Laboratories Limited
  • 9.2.2 NAL Pharma
  • 9.2.3 Cure Pharmaceutical Holding Corp
  • 9.2.4 IntelGenx Corp
  • 9.2.5 Kyu Kyu Pharmaceutical Co. Ltd
  • 9.2.6 Sunovion Pharmaceuticals Inc
  • 9.2.7 Seoul Pharma Co. Ltd
  • 9.2.8 Aquestive Therapeutics Inc
  • 9.2.9 Shilpa Therapeutics Pvt. Ltd
  • 9.2.10 Mylan Inc
  • 9.2.11 LIVKON Pharmaceuticals Pvt. Ltd